115 related articles for article (PubMed ID: 3408224)
1. Controlled therapeutic trial of IgA nephritis with follow-up renal biopsies.
Woo KT; Chiang GS; Yap HK; Lim CH
Ann Acad Med Singap; 1988 Apr; 17(2):226-31. PubMed ID: 3408224
[TBL] [Abstract][Full Text] [Related]
2. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis.
Woo KT; Edmondson RP; Yap HK; Wu AY; Chiang GS; Lee EJ; Pwee HS; Lim CH
Clin Nephrol; 1987 Feb; 27(2):56-64. PubMed ID: 3549083
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
Shima Y; Nakanishi K; Kaku Y; Ishikura K; Hataya H; Matsuyama T; Honda M; Sako M; Nozu K; Tanaka R; Iijima K; Yoshikawa N;
Pediatr Nephrol; 2018 Nov; 33(11):2103-2112. PubMed ID: 29987456
[TBL] [Abstract][Full Text] [Related]
4. Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide.
Tumlin JA; Lohavichan V; Hennigar R
Nephrol Dial Transplant; 2003 Jul; 18(7):1321-9. PubMed ID: 12808169
[TBL] [Abstract][Full Text] [Related]
5. Effect of fluvastatin and dipyridamole on proteinuria and renal function in childhood IgA nephropathy with mild histological findings and moderate proteinuria.
Kano K; Nishikura K; Yamada Y; Arisaka O
Clin Nephrol; 2003 Aug; 60(2):85-9. PubMed ID: 12940609
[TBL] [Abstract][Full Text] [Related]
6. Effects of triple therapy in IgA nephritis: a follow-up study 5 years later.
Woo KT; Lee GS; Lau YK; Chiang GS; Lim CH
Clin Nephrol; 1991 Aug; 36(2):60-6. PubMed ID: 1934661
[TBL] [Abstract][Full Text] [Related]
7. Combined therapy in children and adolescents with IgA nephropathy.
Murakami K; Yoshioka K; Akano N; Takemura T; Okada M; Aya N; Hino S; Miyazato H; Yagi K; Maki S
Nihon Jinzo Gakkai Shi; 1994 Jan; 36(1):38-43. PubMed ID: 8107307
[TBL] [Abstract][Full Text] [Related]
8. Prospective trial of combined therapy with heparin/warfarin and renin-angiotensin system inhibitors in progressive IgA nephropathy.
Ishii T; Kawamura T; Tsuboi N; Ogura M; Utsunomiya Y; Hosoya T
Contrib Nephrol; 2007; 157():114-9. PubMed ID: 17495447
[TBL] [Abstract][Full Text] [Related]
9. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
McIntyre CW; Fluck RJ; Lambie SH
Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
[TBL] [Abstract][Full Text] [Related]
10. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
Fernandes PF; Júnior GB; Barros FA; Sousa DC; Franco LM; Patrocínio RM
Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
[TBL] [Abstract][Full Text] [Related]
11. Early intensive therapy for clinical remission of active IgA nephropathy: a three-year follow-up study.
Hotta O; Taguma Y; Kurosawa K; Sudo K; Suzuki K; Horigome I
Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):967-73. PubMed ID: 8255008
[TBL] [Abstract][Full Text] [Related]
12. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
Walker RG; Yu SH; Owen JE; Kincaid-Smith P
Clin Nephrol; 1990 Sep; 34(3):103-7. PubMed ID: 2225560
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of mesangial areas in serial biopsied patients with IgA nephropathy.
Tateno S; Kobayashi Y
Nephron; 1987; 46(1):28-33. PubMed ID: 3600909
[TBL] [Abstract][Full Text] [Related]
14. Follow-up renal biopsies in IgA nephritic patients on triple therapy.
Woo KT; Chiang GS; Lim CH
Clin Nephrol; 1987 Dec; 28(6):304-5. PubMed ID: 3442958
[No Abstract] [Full Text] [Related]
15. IgA nephritis in Singapore: clinical, prognostic indices, and treatment.
Woo KT; Chiang GS; Lau YK; Lim CH
Semin Nephrol; 1987 Dec; 7(4):379-81. PubMed ID: 3445021
[No Abstract] [Full Text] [Related]
16. Treatment of severe IgA nephropathy in children.
Andreoli SP; Bergstein JM
Pediatr Nephrol; 1989 Jul; 3(3):248-53. PubMed ID: 2702102
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of methylprednisolone, cyclophosphamide in pediatric IgA nephropathy assessed by renal biopsy.
Jiang XY; Mo Y; Sun LZ; Yue ZH; Chen SM; Wu W
Clin Nephrol; 2009 Jun; 71(6):625-31. PubMed ID: 19473630
[TBL] [Abstract][Full Text] [Related]
18. Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy.
Tumlin JA; Hennigar RA
Semin Nephrol; 2004 May; 24(3):256-68. PubMed ID: 15156530
[TBL] [Abstract][Full Text] [Related]
19. Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.
Xu K; Zhang L; Ding J; Wang S; Su B; Xiao H; Wang F; Zhong X; Li Y
J Nephrol; 2018 Apr; 31(2):279-286. PubMed ID: 29185209
[TBL] [Abstract][Full Text] [Related]
20. Controlled trial of antiplatelet agents in mesangial IgA glomerulonephritis.
Chan MK; Kwan SY; Chan KW; Yeung CK
Am J Kidney Dis; 1987 May; 9(5):417-21. PubMed ID: 3555016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
